瘤细胞作为自我维持的cDC1编程工厂的现场工程,用于有效的癌症免疫疗法
Shuiling Jin1, Xiaoxi Wang2, Bingyu Li2
1Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|November 3, 2025
概括
工程外细胞囊泡重编程瘤细胞以吸引和激活树突细胞 (cDC1s),增强抗瘤免疫力并防止复发. 这种方法可以增强免疫记忆,并对抗瘤生长.
科学领域:
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
- 癌症研究 癌症研究
背景情况:
- 传统的1型树突细胞 (cDC1s) 对抗瘤免疫至关重要,但在瘤微环境中往往不足和功能失调.
- 瘤透cDC1s对于启动和调节有效的抗癌免疫反应至关重要.
- 克服瘤中的cDC1限制是癌症免疫疗法的关键挑战.
研究的目的:
- 设计来自瘤的细胞外囊泡 (EVs),将瘤细胞重新编程为本地工厂,用于cDC1的招募和激活.
- 通过克服cDC1缺乏和瘤微环境中的功能障碍来增强抗瘤免疫反应.
- 开发一种新的治疗策略,用于癌症免疫治疗,使用工程EVs.
主要方法:
- 工程瘤衍生的EV (AS16-EL@MPLA/p-FX) 装有编码XCL1和FLT3L.L的等离子体.
- 利用EV特性进行瘤选择性积累和细胞内化.
- 包含MPLA用于TLR4介导的cDC1激活和AS16来破坏VEGF-NRP1相互作用以防止cDC1耗尽.
主要成果:
- 工程 EVs 证明了增强的瘤向和瘤细胞的有效吸收.
- 重编程的瘤细胞分泌XCL1和FLT3L,有效地招募和分化cDC1s.
- MPLA激活了招募的cDC1s,而AS16阻止了cDC1的耗尽,导致显著的瘤生长抑制.
- 治疗诱导了强大的免疫记忆反应,防止转移和复发.
结论:
- 工程EV可以将瘤细胞重新编程为in situcDC1编程和激活中心.
- 这种策略克服了cDC1透和在瘤微环境中的功能限制.
- AS16-EL@MPLA/p-FX方法显示了增强癌症免疫治疗和建立长期抗瘤免疫力的巨大潜力.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Stem Cells and Tumor Maintenance
5.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.9K
Cancer Vaccines
945
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
945
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K


